XAF1 AS A PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET IN PANCREATIC CANCER

(1) Department of Gastroenterology

(2) Department of Pathology, Rui Jin Hospital, Shanghai, China



This item was part of the Pancreatic and liver cancer session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A18